Using psychological principles to narrow the intention-behavior gap and increase participation in HIV vaccine trials

Current HIV Research

Volumn 10, Issue 6, 2012, Pages 552-556

  Poole, Gary ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

HIV vaccine trials; Psychological factors; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DECISION MAKING; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT PARTICIPATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGIST; STUDY DESIGN;

AIDS VACCINES; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MALE; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PATIENT SELECTION; PSYCHOMETRICS;

EID: 84866314307     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016212802429811     Document Type: Article

References (26)

1. Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A. Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004; 36: 604-612.
2. Halpern SD, Metzger DS, Berlin JA, et al. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr 2001; 27: 281-288.
3. Eagly AH, The psychology of attitudes. Orlando: Harcourt, Brace Jovanovich 1993.
4. Wicker AW. Attitude versus actions: The relationship of verbal and overt behavioral response to attitude objects. J Soc Issues 1969; 25(4): 41-78.
5. Turchik JA, Gidycz CA. Exploring the intention-behavior relationship in the prediction of sexual risk behaviors: Can it be strengthened? J Sex Res 2012; 49(1): 50-60.
6. Orbell S, Sheeran P. Inclined abstainers": A problem for predicting health-related behavior. Brit J Soc Psychol 1998; 37: 151-165.
7. Dhalla S, Nelson KE, Singer J, Poole G. HIV vaccine preparedness studies in the non-organization for economic co-operation and development (non-OECD) countries. Aids Care 2009; 21(3): 335-348.
8. Dhalla S, Woods R, Strathdee SA, Patrick D, Hogg RS. HIV vaccine preparedness studies in the organization for economic cooperation and development (OECD) countries. AIDS Care 2007; 19: 1118-1127.
9. Ajzen I, Fishbein M. Attitude-behavior relations: A theoretical analysis and review of empirical research. Psychol Bull; 1977; 84: 888-918.
10. Sheeran P. Intention-behavior relationships: A conceptual and empirical review. Eur Rev Soc Psychol 2002; 12: 1-36.
11. Olin J, Kokolamami J, Lepira FB, et al. Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Cult Health Sex 2006; 8(6); 529-544.
12. Ritvo P, Willms D, Meisner R, Brown L, Goldman A, Sewankambo N. Vaccine preparedness: lessons from Lyantonde, Uganda. Afr J AIDS Res 2006; 5(1): 11-16.
13. Dhalla S, Poole G. Motivators of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studies. Aids Care 2011; 23(11): 1430-1447.
14. Dhalla S, Poole G, Singer J, Patrick D, Wood E, Kerr T. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users. Vaccine 2010; 28(7): 1663-1667.
15. Gollwitzer P, Sheeran P. Implementation intentions and goal achievement: A meta-analysis of effects and processes. Adv Exp Soc Psychol 2006; 38: 69-119.
16. Bagozzi RP, Yi, Y. The degree of intention formation as a moderator of the attitude-behavior relationship. Soc Psychol Q 1989; 52: 266-279.
17. Parker D, Manstead ASR, Stradling SG. Extending the theory of planned behavior: The role of personal norm. Brit J Soc Psychol 1995; 34: 127-137.
18. Bartholow BN, MacQueen KM, Douglas JM Jr., Buchbinder S, McKirnan D, Judson FN. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquired Immune Defic Syndr Hum Retrovirol 1997; 16(2): 108-115.
19. Golub ET, Purvis L., Sapun M, et al. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Beh 2005; 9(3): 301-309.
20. O'Connell JM, Hogg RS, Cha K, et al. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. JAIDS 2002; 31: 521-528.
21. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall 1980.
22. Deci E, Ryan R. Intrinsic motivation and self-determination in human behavior. London: Plenum 1985.
23. Dhalla S, Poole G. Barriers to participation in an HIV vaccine trial. Vaccine, 2011; 29(35): 5850-5859.
24. Newman PA, Duan N, Sung-Jae L, et al. Willingness to participate in HIV vaccine trials: The impact of trial attributes. Prev Med 2007; 44(6); 554-557.
25. Hallaq J. The pledge as an instrument of behavioral change. J Soc Psychol 1976; 98: 147-148.
26. Herber OR, Bradbury-Jones C. Cross my heart and hope to die: The use of pledges in health care. J Clin Nurs 2011; 20(21-22): 2981-2983.